Results 1 to 10 of about 18,796 (241)

COVID-19 Dysautonomia [PDF]

Frontiers in Neurology, 2021
Objective: To report a case series of dysautonomia associated with COVID-19 infection.Methods: This is a retrospective review of patients evaluated in the autonomic clinic at our institution with suspected signs and symptoms of dysautonomia who underwent
Brent P. Goodman, Julie A. Khoury, Janis E. Blair, Marie F. Grill   +3 more
doaj   +4 more sources

Cardiac 123I-MIBG uptake in de novo Brazilian patients with Parkinson's disease without clinically defined dysautonomia [PDF]

Arquivos de Neuro-Psiquiatria, 2014
Myocardial scintigraphy with meta-iodo-benzyl-guanidine (123I cMIBG) has been studied in Parkinson's disease (PD), especially in Asian countries, but not in Latin America.
Marco Antonio Araujo Leite, Osvaldo J. M. Nascimento, João Santos Pereira, Clayton Amaral, Cláudio T. Mesquita, Jader C. Azevedo, Adriana S. X. de Brito, Felipe Villela Pedras   +7 more
doaj   +2 more sources

Evaluating the risk and risk factors of dysautonomia as a post-acute sequelae of COVID-19: a secondary analysis of a matched case–control dataset [PDF]

Frontiers in Neurology
BackgroundA significant proportion of patients presenting with post-acute sequelae of COVID-19 (PASC) have been found to meet diagnostic criteria for certain disorders of the autonomic nervous system. Substantial gaps remain in our understanding of these
Benjamin C. Pierson, Megan Clare Craig-Kuhn, Megan Clare Craig-Kuhn, Laveta Stewart, Laveta Stewart, Erica Sercy, Erica Sercy, Caryn A. Stern, Brock Graham, Amber Michel, Amber Michel, Edward Parmelee, Edward Parmelee, Tracey Perez Koehlmoos, David Saunders, James D. Mancuso, Simon Pollett, Simon Pollett, Timothy Burgess, David R. Tribble   +19 more
doaj   +2 more sources

Immune Checkpoint Inhibitor‐Related Dysautonomia in Merkel Cell Carcinoma: A Case Report [PDF]

Cancer Reports
Background Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block inhibitory pathways that cancer cells exploit to suppress T‐cell activation.
Nidhi Kuchimanchi, Sai Gajula, Elizabeth M. Gaughan, Russell G. Witt   +3 more
doaj   +2 more sources

Pathologic fracture of mandibular ramus in a patient with familial dysautonomia: A case report

Oral and Maxillofacial Surgery Cases
Familial dysautonomia is a rare disease that impairs the development of sensory nerves, afferent autonomic nerves, and afferent baroreflex pathways.
Patrick J. Nolan, David Koslovsky, Drew Roberts   +2 more
doaj   +2 more sources

Comparison of Dysautonomia Across Species: Current Knowledge and Future Research Opportunities [PDF]

Journal of Veterinary Internal Medicine
Primary dysautonomia is a complex and often fatal autonomic nervous system disease. This literature review consolidates information on dysautonomia across species.
Callum N. Atkins, Caroline N. Hahn, Bruce C. McGorum   +2 more
doaj   +2 more sources

Familial Dysautonomia [PDF]

BMJ, 1965
Y R, AHUJA, H, FUDENBERG
openaire   +4 more sources

Long-term potentiation and neurotransmitters expression and segregation are altered in the Metabolic Syndrome-associated dysautonomia. [PDF]

PLoS One
Elinos D, Veladiz-Gracia F, González-Sierra C, Rubio-Galicia A, Cifuentes F, Morales MA.   +5 more
europepmc   +2 more sources

Dysautonomia awareness month

Medical Journal of Dr. D.Y. Patil Vidyapeeth, 2022
Jamir Pitton Rissardo, Ana Leticia Fornari Caprara   +1 more
doaj   +2 more sources

Cervicovagopathy: ligamentous cervical instability and dysstructure as a potential etiology for vagus nerve dysfunction in the cause of human symptoms and diseases [PDF]

Frontiers in Neurology
Vagus nerve dysfunction is implicated in the pathophysiology of many different symptoms and diseases that plague humanity. In many cases, the etiology of this condition remains elusive.
Ross A. Hauser, Danielle Matias, Benjamin Ryan Rawlings   +2 more
doaj   +2 more sources